85
th Legislative Session _ 2010
Committee: Senate Health and Human Services
Monday, February 01, 2010
P - Present
E - Excused
A - Absent
Roll Call
P Dempster
P Gant
P Hansen (Tom), Vice-Chair
P Jerstad
P Merchant
E Miles
P Adelstein, Chair
OTHERS PRESENT: See Original Minutes
The meeting was called to order by Senator Stanford Adelstein, Chair.
MOTION: TO APPROVE THE MINUTES OF WEDNESDAY, JANUARY 27, 2010
Moved by: Dempster
Second by: Gant
Action: Prevailed by voice vote.
SB 74: repeal the prohibition against stem cell treatments and research and to
establish ethical guidelines to regulate stem cell research.
Presented by: Senator Ben Nesselhuf (Handouts: Handout:1,2)
Proponents: Dr. Doris Taylor, Self, Minnespolis, Minnesota, Teleconference
Jacob Bly, Self, Pierre
Patricia Brooks, National MS Society, Sioux Falls
Ryan Green, Self, Sioux Falls
Dorothy Brewick, Self, Rapid City
Opponents: Dr. Theresa Deisher, Self, Seattle, WA, Teleconference
Chris Hupke, SD Family Policy Council (Handouts: Handout 3,4)
Rita Houglum, Eagle Forum
Linda Schauer, Concerned Women For America
George Dummann, SD Right to Life, Pierre (Handouts: Handout 5)
Deb Fischer Clemens, Avera Health
Dena Espenscheid, Self, Sioux Falls
MOTION: AMEND SB 74
74ja
On the printed bill, delete everything after the enacting clause and insert:
" Section 1. That chapter 34-14 be amended by adding thereto a NEW SECTION to read as
follows:
Nothing in this chapter prohibits the use of any Food and Drug Administration approved
treatments derived from or involving human embryonic stem cells."
Moved by: Merchant
Second by: Dempster
Action: Failed by roll call vote. (3-3-1-0)
Voting Yes: Dempster, Hansen (Tom), Adelstein
Voting No: Gant, Jerstad, Merchant
Excused: Miles
MOTION: RECONSIDER SB 74 AMENDMENT
Moved by: Dempster
Second by: Merchant
Action: Prevailed by roll call vote. (4-2-1-0)
Voting Yes: Dempster, Jerstad, Merchant, Adelstein
Voting No: Gant, Hansen (Tom)
Excused: Miles
MOTION: AMEND SB 74
74ja
On the printed bill, delete everything after the enacting clause and insert:
" Section 1. That chapter 34-14 be amended by adding thereto a NEW SECTION to read as
follows:
Nothing in this chapter prohibits the use of any Food and Drug Administration approved
treatments derived from or involving human embryonic stem cells."
Moved by: Merchant
Second by: Dempster
Action: Prevailed by roll call vote. (4-2-1-0)
Voting Yes: Dempster, Jerstad, Merchant, Adelstein
Voting No: Gant, Hansen (Tom)
Excused: Miles
MOTION: AMEND TITLE OF SB 74
74jta
On page 1, line 1, of the printed bill, delete everything after "to" and insert "clarify the use of
treatments involving human embryonic stem cells.".
On page 1, delete line 2.
Moved by: Dempster
Second by: Jerstad
Action: Prevailed by voice vote.
MOTION: DO PASS SB 74 AS AMENDED
Moved by: Dempster
Second by: Jerstad
Action: Prevailed by roll call vote. (4-2-1-0)
Voting Yes: Dempster, Jerstad, Merchant, Adelstein
Voting No: Gant, Hansen (Tom)
Excused: Miles
THE CHAIR DEFERRED SB 83 UNTIL WEDNESDAY, FEBRUARY 3, 2010
THE CHAIR DEFERRED SB 92 UNTIL WEDNESDAY, FEBRUARY 3, 2010
MOTION: ADJOURN
Moved by: Hansen (Tom)
Second by: Merchant
Action: Prevailed by voice vote.
Cindy Louder
____________________________
Committee Secretary
Stanford M. Adelstein, Chair
../02010745.SHE
Page 1